David Kaslow, FDA's incoming director of CBER's Office of Vaccines Research and Review

FDA hires new vac­cine di­rec­tor, a year af­ter two se­nior lead­ers quit in protest

Af­ter al­most ex­act­ly a year since the FDA’s top two vac­cine lead­ers left in protest over boost­ers-for-all, the FDA has now named for­mer Mer­ck VP David Kaslow as its new di­rec­tor of CBER’s Of­fice of Vac­cines Re­search and Re­view.

Kaslow will re­place act­ing di­rec­tor Pe­ter Marks (who is al­so head of CBER) af­ter he had to step in to re­place Mar­i­on Gru­ber, who re­signed sud­den­ly along­side her deputy Philip Krause in late 2021 af­ter they dis­agreed with the agency’s boost­er strat­e­gy.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.